// App-Quantinova.ai

: Interest among T1D and T2D Patients Taking Insulin in Adding a New Drug Therapy to Prevent Nocturnal Hypoglycemia

Researchers

Presenter

  • RICHARD LIGGINS

Principal Investigators

  • CLAUDE PICHE

  • MICHAEL RIDDELL

  • RICHARD WOOD

  • CHRISTIANNE PANG

  • MARTIN LAFONTAINE

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Central Nervous System (CNS)

Disease

  • Hyperglycemia

  • Anxiety

Biomarkers

  • Insulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved